Dominique Aubert

Title: Innovations of Dominique Aubert in Biotechnology

Introduction

Dominique Aubert is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and nucleic acids. With a total of 10 patents to his name, Aubert's work has advanced our understanding and application of biotechnological processes.

Latest Patents

One of his latest patents focuses on polypeptides having cellobiohydrolase I activity and the polynucleotides encoding these polypeptides. This invention relates to the identification and utilization of polypeptides that exhibit specific enzymatic activities. The patent also encompasses nucleic acid constructs, vectors, and host cells that incorporate these constructs, along with methods for producing and utilizing the polypeptides effectively.

Career Highlights

Dominique Aubert is currently associated with Novozymes A/S, a leading company in the field of biotechnology. His work at Novozymes has allowed him to explore innovative solutions that enhance the efficiency of biotechnological applications. His research has not only contributed to the company's portfolio but has also had a broader impact on the industry.

Collaborations

Aubert has collaborated with notable colleagues such as Lene Lange and Wenping Wu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their respective fields.

Conclusion

Dominique Aubert's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence advancements in biotechnological applications, showcasing the importance of innovation in this field.